Indústrias
Showing 11–20 de 21 resultados
-
Global Vaccines Market
The global vaccines market was around 32 billion USD in 2019, reached 41 billion USD in 2020 (an increase of 26.3% year-on-year), de acordo com StrategyHelix’ análise.
-
Global Hyaluronic Acid Market
The global hyaluronic acid market was around 582 tons in 2019, reached 598 tons in 2020 (an increase of 2.8% year-on-year), de acordo com StrategyHelix.
-
Global mRNA Pharmaceutical (ex COVID-19) Mercado
The global mRNA pharmaceutical (ex COVID-19) market is poised to grow by US$ 3,207 milhões durante 2021-2027, progredindo em um CAGR de 9.7% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.
-
Global Oral Care Market
The global oral care market is set to grow at a healthy compound annual growth rate (CAGR) de 4.1% in the next five years.
-
Global APIs (Active Pharmaceutical Ingredients) Mercado
Following a mild (5.9%) rise in 2019, the global APIs (active pharmaceutical ingredients) market in terms of revenue declined dramatically (-6.8%), reaching 163 billion USD in 2020, de acordo com StrategyHelix.
-
Global Pharmaceutical R&D Spending Market
The global pharmaceutical R&D spending market is anticipated to expand positively at a CAGR of 6.8% durante o período de previsão (2021-2027), de acordo com StrategyHelix.
-
Global CRO (Contract Research Organization) Mercado
A statistic by StrategyHelix indicates that the global CRO (contract research organization) market is expected to increase at a CAGR of 9.9% até 2027.
-
Global Medical Device Market
A statistic by StrategyHelix indicates that the global medical device market is expected to increase by US$ 216 bilhão de 2021 para 2027, obtendo um CAGR de 5.7% durante o período de previsão.
-
Global BCI (Brain-computer Interface) Mercado
The global BCI (brain-computer interface) market is poised to grow by US$ 1,967 milhões durante 2021-2027, progredindo em um CAGR de 15.3% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.
-
Global CAR (Chimeric Antigen Receptor) T-Cell Therapy Market
The global CAR (chimeric antigen receptor) T-cell therapy market is poised to grow by US$ 14,302 milhões de 2021 para 2027, registrando um CAGR de 42.5% durante o período de previsão, de acordo com StrategyHelix.